Stifel Financial Corp Iovance Biotherapeutics, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 223,107 shares of IOVA stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,107

Previous 164,320 35.78%

Holding current value

$1.65 Million

Previous $1.32 Million 59.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $427,969 - $699,565	58,787 Added 35.78%	223,107 $2.09 Million
Q2 2024 Aug 13, 2024	SELL	$7.78 - $14.19 $731,125 - $1.33 Million	-93,975 Reduced 36.38%	164,320 $1.32 Million
Q1 2024 May 13, 2024	SELL	$7.59 - $17.47 $382,983 - $881,518	-50,459 Reduced 16.34%	258,295 $3.83 Million
Q4 2023 Feb 12, 2024	BUY	$3.3 - $8.89 $259,380 - $698,754	78,600 Added 34.15%	308,754 $2.51 Million
Q3 2023 Nov 13, 2023	SELL	$4.44 - $8.79 $427,034 - $845,413	-96,179 Reduced 29.47%	230,154 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $951,078 - $1.61 Million	177,440 Added 119.17%	326,333 $2.3 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $60,653 - $90,156	10,968 Added 7.95%	148,893 $909,000
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $775,138 - $1.38 Million	137,925 New	137,925 $881,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $144,564 - $241,348	-8,735 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $2,747 - $3,595	135 Added 1.57%	8,735 $215,000
Q2 2021 Aug 13, 2021	SELL	$16.33 - $33.07 $305,403 - $618,475	-18,702 Reduced 68.5%	8,600 $224,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $140,941 - $258,532	-4,916 Reduced 15.26%	27,302 $864,000
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $26,385 - $47,294	941 Added 3.01%	32,218 $1.5 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $29,137 - $38,115	1,050 Added 3.47%	31,277 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $59,399 - $89,503	-2,183 Reduced 6.74%	30,227 $830,000
Q1 2020 May 14, 2020	SELL	$19.54 - $38.85 $136,193 - $270,784	-6,970 Reduced 17.7%	32,410 $969,000
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $706,871 - $1.16 Million	39,380 New	39,380 $1.09 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Iovance Biotherapeutics, Inc. Transaction History